Export 549 results:
Author Title Type [ Year(Desc)]
Filters: Keyword is Alzheimer Disease  [Clear All Filters]
E. Audronyte, Pakulaite-Kazliene, G., Sutnikiene, V., and Kaubrys, G., Odor Discrimination as a Marker of Early Alzheimer's Disease., J Alzheimers Dis, vol. 94, no. 3, pp. 1169-1178, 2023.
Z. - Di Xia, Ma, R. - X., Wen, J. - F., Zhai, Y. - F., Wang, Y. - Q., Wang, F. - Y., Liu, D., Zhao, X. - L., Sun, B., Jia, P., and Zheng, X. - H., Pathogenesis, Animal Models, and Drug Discovery of Alzheimer's Disease., J Alzheimers Dis, vol. 94, no. 4, pp. 1265-1301, 2023.
R. Olmos-Villaseñor, Sepulveda-Silva, C., Julio-Ramos, T., Fuentes-Lopez, E., Toloza-Ramirez, D., Santibañez, R. A., Copland, D. A., and Mendez-Orellana, C., Phonological and Semantic Fluency in Alzheimer's Disease: A Systematic Review and Meta-Analysis., J Alzheimers Dis, vol. 95, no. 1, pp. 1-12, 2023.
M. Rafi Khezri, Ghasemnejad-Berenji, M., and Moloodsouri, D., The PI3K/AKT Signaling Pathway and Caspase-3 in Alzheimer's Disease: Which One Is the Beginner?, J Alzheimers Dis, vol. 92, no. 2, pp. 391-393, 2023.
P. Chatterjee, Doré, V., Pedrini, S., Krishnadas, N., Thota, R., Bourgeat, P., Ikonomovic, M. D., Rainey-Smith, S. R., Burnham, S. C., Fowler, C., Taddei, K., Mulligan, R., Ames, D., Masters, C. L., Fripp, J., Rowe, C. C., Martins, R. N., and Villemagne, V. L., Plasma Glial Fibrillary Acidic Protein Is Associated with 18F-SMBT-1 PET: Two Putative Astrocyte Reactivity Biomarkers for Alzheimer's Disease., J Alzheimers Dis, vol. 92, no. 2, pp. 615-628, 2023.
Y. Jayne Tan, Siow, I., Saffari, S. Ehsan, Ting, S. K. S., Li, Z., Kandiah, N., Tan, L. C. S., Tan, E. King, and Ng, A. S. L., Plasma Soluble ST2 Levels Are Higher in Neurodegenerative Disorders and Associated with Poorer Cognition., J Alzheimers Dis, vol. 92, no. 2, pp. 573-580, 2023.
C. S. Atwood and Perry, G., Playing Russian Roulette with Alzheimer's Disease Patients: Do the Cognitive Benefits of Lecanemab Outweigh the Risk of Edema, Stroke and Encephalitis?, J Alzheimers Dis, vol. 92, no. 3, pp. 799-801, 2023.
D. E. Bredesen, Toups, K., Hathaway, A., Gordon, D., Chung, H., Raji, C., Boyd, A., Hill, B. D., Hausman-Cohen, S., Attarha, M., Chwa, W. Jong, Kurakin, A., and Jarrett, M., Precision Medicine Approach to Alzheimer's Disease: Rationale and Implications., J Alzheimers Dis, vol. 96, no. 2, pp. 429-437, 2023.
S. L. Cody, Miller, G. H., Fazeli, P. L., Wang, G., Li, W., Goodin, B. R., and Vance, D. E., Preventing Neurocognitive Decline in Adults Aging with HIV: Implications for Practice and Research., J Alzheimers Dis, vol. 95, no. 3, pp. 753-768, 2023.
K. Katisko, Krüger, J., Soppela, H., Hartikainen, P., Haapasalo, A., Remes, A. M., and Solje, E., Psychopharmacological Medication Use in Frontotemporal Dementia at the Time of Diagnosis: Comparison with Alzheimer's Disease., J Alzheimers Dis, vol. 95, no. 2, pp. 677-685, 2023.
M. Pacheco Pachado, Casas, A. I., Elbatreek, M. H., Nogales, C., Guney, E., Espay, A. J., and Schmidt, H. H. H. W., Re-Addressing Dementia by Network Medicine and Mechanism-Based Molecular Endotypes., J Alzheimers Dis, vol. 96, no. 1, pp. 47-56, 2023.
S. Patel, Wei, J., Shi, Z., Rifkin, A. S., S Zheng, L., Gelfman, E., Duggan, D., Helfand, B. T., Hulick, P. J., and Xu, J., Refining Risk for Alzheimer's Disease Among Heterozygous APOEɛ4 Carriers., J Alzheimers Dis, vol. 94, no. 2, pp. 483-489, 2023.
K. Surya, Manickam, N., Jayachandran, K. Swaminatha, Kandasamy, M., and Anusuyadevi, M., Resveratrol Mediated Regulation of Hippocampal Neuroregenerative Plasticity via SIRT1 Pathway in Synergy with Wnt Signaling: Neurotherapeutic Implications to Mitigate Memory Loss in Alzheimer's Disease., J Alzheimers Dis, vol. 94, no. s1, pp. S125-S140, 2023.
M. Pejstrup Agger, Danielsen, E. Rubæk, Carstensen, M. Schultz, N Nguyen, M., Horning, M., Henney, M. Alexander, Jensen, C. Boe Ravn, Baandrup, A. Ohlhues, Kjær, T. Wesenberg, Madsen, K. Hougaard, Miskowiak, K., Petersen, P. Michael, and Høgh, P., Safety, Feasibility, and Potential Clinical Efficacy of 40 Hz Invisible Spectral Flicker versus Placebo in Patients with Mild-to-Moderate Alzheimer's Disease: A Randomized, Placebo-Controlled, Double-Blinded, Pilot Study., J Alzheimers Dis, vol. 92, no. 2, pp. 653-665, 2023.
G. S. Smith, Kuwabara, H., Yan, H., Nassery, N., Yoon, M., Kamath, V., Kraut, M., Gould, N. F., Savonenko, A., Coughlin, J. M., Lodge, M., Pomper, M. G., Nandi, A., Holt, D., Dannals, R. F., and Leoutsakos, J. M., Serotonin Degeneration and Amyloid-β Deposition in Mild Cognitive Impairment: Relationship to Cognitive Deficits., J Alzheimers Dis, vol. 96, no. 1, pp. 215-227, 2023.
C. Wu, Ma, Y. - H., Hu, H., Zhao, B., and Tan, L., Soluble TREM2, Alzheimer's Disease Pathology, and Risk for Progression of Cerebral Small Vessel Disease: A Longitudinal Study., J Alzheimers Dis, vol. 92, no. 1, pp. 311-322, 2023.
A. Loughman, Adler, C. J., and Macpherson, H., Unlocking Modifiable Risk Factors for Alzheimer's Disease: Does the Oral Microbiome Hold Some of the Keys?, J Alzheimers Dis, vol. 92, no. 4, pp. 1111-1129, 2023.
S. Chand Basha, Ramaiah, M. Janaki, and Kosagisharaf, J. Rao, Untangling the Role of TREM2 in Conjugation with Microglia in Neuronal Dysfunction: A Hypothesis on a Novel Pathway in the Pathophysiology of Alzheimer's Disease., J Alzheimers Dis, vol. 94, no. s1, pp. S319-S333, 2023.
H. Shinagawa, Ohuchi, K., Goto, Y., Hashimoto, K., Kijima, H., Maekawa, S., Kurita, H., and Inden, M., Vacuolar Protein-Sorting Proteins Are Reduced Even Before Cognitive Decline in a Mouse Model of Alzheimer's Disease., J Alzheimers Dis, vol. 96, no. 3, pp. 1011-1017, 2023.
F. Rajabli, Seixas, A. A., Akgun, B., Adams, L. D., Inciute, J., Hamilton, K. L., Whithead, P. G., Konidari, I., Gu, T., Arvizu, J., Golightly, C. G., Starks, T. D., Laux, R., Byrd, G. S., Haines, J. L., Beecham, G. W., Griswold, A. J., Vance, J. M., Cuccaro, M. L., and Pericak-Vance, M. A., African Ancestry Individuals with Higher Educational Attainment Are Resilient to Alzheimer's Disease Measured by pTau181., J Alzheimers Dis, vol. 98, no. 1, pp. 221-229, 2024.
A. Mahzarnia, Lutz, M. W., and Badea, A., A Continuous Extension of Gene Set Enrichment Analysis Using the Likelihood Ratio Test Statistics Identifies Vascular Endothelial Growth Factor as a Candidate Pathway for Alzheimer's Disease via ITGA5., J Alzheimers Dis, vol. 97, no. 2, pp. 635-648, 2024.
I. Frentz, van Arendonk, J., Leeuwis, A. E., Vernooij, M. W., van der Flier, W. M., Bos, D., De Deyn, P. Paul, Wolters, F. J., and M Ikram, A., Interaction Between Arteriosclerosis and Amyloid-β on Cognitive Function., J Alzheimers Dis, vol. 97, no. 2, pp. 953-961, 2024.
O. Almkvist, Larsson, M., and Graff, C., Odor Identification Across Time in Mutation Carriers and Non-Carriers in Autosomal-Dominant Alzheimer's Disease., J Alzheimers Dis, vol. 97, no. 2, pp. 587-598, 2024.
M. Safieh, Liraz, O., Ovadia, M., and Michaelson, D., The Role of Impaired Receptor Trafficking in Mediating the Pathological Effects of APOE4 in Alzheimer's Disease., J Alzheimers Dis, vol. 97, no. 2, pp. 753-775, 2024.